Catherine Rycroft

Catherine Rycroft has extensive work experience in the field of healthcare and value communication. Catherine is currently a Senior Director at Lumanity, where they serve as the Global Head of Value Communications Services and the Senior Director of HTA and Value Communications. Prior to joining Lumanity, Catherine worked at BresMed, where they held various roles including Senior Director of Clinical Evidence Review and Head of Value Communications Services. Catherine also served as a Principal Research Associate and Senior Market Access Consultant at BresMed. Catherine has contributed to the Ethnicity and COVID-19 Research Consortium (ECRC) as a Research Volunteer. Earlier in their career, they worked at RTI Health Solutions as an Associate Director and Senior Associate in Market Access and Outcomes Strategy. Catherine also gained experience as a Medical Writer at Prime Medica and as a Senior Research Scientist at F2G. Catherine began their professional journey as a PhD Student at the University of Reading.

Catherine Rycroft obtained a PhD in Microbiology from the University of Reading, where they studied between 1997 and 2001.